Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 64

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 64
---
                                      |

The securities will be
offered at a fixed combined public offering price and are expected to be issued in a single closing. We expect this offering to be completed
on or about July 16, 2025.

We expect to deliver
the shares and securities to the purchasers in the offering on or about July 16, 2025, subject to satisfaction of certain conditions.

Fees and Expenses

The following table shows
per share and accompanying Warrants and per Pre-Funded Warrant and accompanying Warrants placement agent fees and total placement agent
fees we will pay in connection with the sale of the securities in this offering.

| Per share and Common Warrants placement agent cash fees              |     | $ |     0.1425 |
| Per Pre-Funded Warrant and Common Warrants placement agent cash fees |     | $ |     0.1425 |
| Total                                                                |     | $ | 374,999.87 |

We have agreed to pay
the placement agent a total cash fee equal to 7.5% of the gross proceeds of this offering and a management fee equal to 1.0% of the gross
proceeds raised in this offering. We will also pay the placement agent a non-accountable expense allowance of $10,000, $5,000 for the
expenses of its clearing firm, and will reimburse the placement agent for its road show expenses in addition to up to $100,000 to cover
its legal fees and expenses. We estimate the total offering expenses of this offering that will be payable by us, excluding the placement
agent’s fees and expenses, will be approximately $0.3 million. After deducting the placement agent’s fees and our estimated
offering expenses, we expect the net proceeds from this offering to be approximately $4.2 million.

<div align='center'>34</div>

Placement Agent Warrants

We have agreed to
grant Placement Agent Warrants to the placement agent or its designees to purchase a number of shares of our common stock equal to
7.5% of the aggregate number of shares of common stock and Pre-Funded Warrants sold to the investors in this offering, or warrants
to purchase an aggregate of up to 197,368 shares of common stock. The Placement Agent Warrants will have an exercise price equal to
125% of the combined public offering price per share of common stock and accompanying Warrants, or $2.375 per share, and will
terminate on the